Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides
Meeting report with presentation slides, videos and online CME of a PACE-CME symposium held during ESC 2020, The Digital Experience.
1
1-5 of 5
Novel opportunities tackling residual cardiovascular risk: The evolving role of triglyceridesIntroduction: The evolving role of triglycerides
prof. Paul Ridker, MD
- Novel opportunities tackling residual cardiovascular risk: The evolving role of triglyceridesLessons from REDUCE-IT
Deepak Bhatt, MD
- Novel opportunities tackling residual cardiovascular risk: The evolving role of triglyceridesNon-LDL-c parameters in CV risk management and guidelines
Prof Kausik Ray
- Novel opportunities tackling residual cardiovascular risk: The evolving role of triglyceridesThe residual risk challenge in CVD: How important are triglycerides?
Prof. Ulf Landmesser
- Novel opportunities tackling residual cardiovascular risk: The evolving role of triglyceridesDiscussion: Novel opportunities tackling residual cardiovascular risk: The evolving role of triglycerides